Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2017 | |
| Sales | 22 |
| Gross Profit | 22 |
| Operating Expenses | 3,999 |
| Operating Income | -3,977 |
| Other Income | -2,106 |
| Pre-tax Income | -6,083 |
| Net Income Continuous | -6,083 |
| Net Income | $-6,083 |
| EPS Basic Total Ops | -40.77 |
| EPS Basic Continuous Ops | -36.56 |
| EPS Diluted Total Ops | -40.77 |
| EPS Diluted Continuous Ops | -36.56 |
| EBITDA(a) | $-3,977 |